University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: CuraScript Specialty Distribution, Lake Mary, FL
Amount: An estimated $3,000,000
An estimated start date of 7/1/2020 through 6/30/2025
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, April 6, 2020
The University awarded a contract for transplant and respiratory pharmaceuticals.
Mychophenolic Acid Tablets, Tacrolimus Tablets, Albuterol Inhalers, Hydroxychloroquine Tablets, immunosurpressants for transplant patients, and bronchodilators for respiratory treatments.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) These products treat transplant patients and respiratory diseases. For transplant there have been shortages of transplant drugs for about a year now and this will supplement our primary supply chain. The respiratory products are needed due to short supplies as a result of the COVID-19 pandemic. They may or may not be used directly for COVID-19 patients and will be used to supplement our stressed supply chain.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.